You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 10,123,959


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,123,959
Title:Methods for treating cellulite
Abstract: The invention relates to the discovery that collagenase injections are effective in dissolving and lysing the collagenase septa network in the skin that comprises cellulite. As such, the invention relates to methods of treating cellulite in a patient in need of such treatment comprising injecting or otherwise delivering the effective amount of purified collagenase to the collagenase septa network of cellulite in the skin. The invention also relates to the use of collagenase in the manufacture of a medicament to treat cellulite of the skin.
Inventor(s): Badalamente; Marie A. (Mt. Sinai, NY), Dagum; Alexander B. (Stony Brook, NY)
Assignee: The Research Foundation for The State University of New York (Albany, NY)
Application Number:15/173,092
Patent Claims:1. A method of treating cellulite in a subject in need thereof, comprising the steps of (a) providing a composition consisting essentially of a mixture of purified collagenase I and II in a mass ratio of about 1:1 obtained from Clostridium histolyticum, wherein the mixture has a specific activity of at least 10,000 ABC units per 0.58 mg of collagenase I and II, and (b) injecting the composition to a collagenous septa network of cellulite at a dose of at least 0.18 mg of the mixture of purified collagenase I and II.

2. The method according to claim 1, wherein the mixture of purified collagenase I and II is injected in an absence of triamcinolone or other corticosteroids.

3. The method according to claim 1, wherein the dose of purified collagenase I and II is at least 0.25 mg.

4. The method according to claim 1, wherein the dose of purified collagenase I and II is at least 0.36 mg.

5. The method according to claim 1, wherein the dose of purified collagenase I and II is at least 0.58 mg.

6. The method according to claim 1, wherein the composition further consists essentially of a pharmaceutically acceptable carrier.

7. The method according to claim 1, wherein the mixture of purified collagenase I and II is injected at multiple sites.

8. The method according to claim 1, wherein the injection is delivered in the area of cellulite, characterized by skin dimpling.

9. The method according to claim 1, wherein the subject is a human patient.

10. The method according to claim 1, wherein the treatment is repeated after about four to six weeks.

11. The method according to claim 1, wherein the composition is administered to a population of human subjects and after one month of receiving at least one administration of the mixture of purified collagenase I and II, at least 89% of the subjects achieve a significant visual reduction in the appearance of cellulite quantified by visual inspection by quadrant in comparison to baseline.

12. The method according to claim 1, wherein the dose of purified collagenase I and II is at least 0.55 mg.

13. The method according to claim 1, wherein the dose of purified collagenase I and II is at least 5.48 mg.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.